-transparent.png){kind=logo}
A role for cAMP in the process of LHRH release was suggested several years ago, but only recently has the validity of this notion come under close scrutiny. In the present experiments we have used three probes, which stimulate adenylate cyclase activity via different mechanisms, to determine whether an increase in endogenous cAMP results in LHRH release from the hypothalamus of prepubertal female rats. Median eminences from juvenile, 28-day-old animals were incubated in vitro with either forskolin (F), cholera toxin (CT), or pertussis toxin (PT). All three substances enhanced LHRH release. The estimated ED50 values were 28.7 microM and 20.0 ng/ml, for F and PT, respectively. The effect of CT appeared biphasic and thus no ED50 could be calculated. None of these agents increased the release of prostaglandin E2 (PGE2), an obligatory component in the process of norepinephrine-induced LHRH secretion. Doses of PGE2 and F, which were maximally effective in stimulating LHRH release when administered separately, did not produce any further response when administered concomitantly, thus suggesting that PGE2 and F act along a common pathway. Blockade of phosphodiesterase activity with 1-methyl-3-isobutylxanthine increased LHRH secretion without enhancing PGE2 release, implying that cAMP metabolism was elevated in the median eminence nerve terminals in vitro. Addition of 1-methyl-3-isobutylxanthine augmented the LHRH response to CT and PT, but it did not increase further the already marked LHRH response to PGE2 or F. The results indicate that both an increase in adenylate cyclase activity and a decrease in phosphodiesterase activity lead to LHRH release from the median eminence. They also suggest that, upon proper (neurotransmitter?) stimulation, cAMP production increases subsequent to the activation in PGE2 synthesis, which itself causes LHRH release. Furthermore, the capacity of PT to induce LHRH release suggests the involvement of an inhibitory guanine nucleotide-binding regulatory protein in transducing inhibitory inputs impinging on LHRH-secreting neurons.
S R Ojeda, and
H F Urbanski, and
K H Katz, and
M E Costa
February 1979,
Endocrinology,
S R Ojeda, and
H F Urbanski, and
K H Katz, and
M E Costa
September 1972,
Proceedings of the National Academy of Sciences of the United States of America,
S R Ojeda, and
H F Urbanski, and
K H Katz, and
M E Costa
August 1978,
Endocrinology,
S R Ojeda, and
H F Urbanski, and
K H Katz, and
M E Costa
June 1984,
Endocrinology,
S R Ojeda, and
H F Urbanski, and
K H Katz, and
M E Costa
June 1992,
Endocrinology,
S R Ojeda, and
H F Urbanski, and
K H Katz, and
M E Costa
March 1969,
Science (New York, N.Y.),
S R Ojeda, and
H F Urbanski, and
K H Katz, and
M E Costa
January 1975,
Neuroendocrinology,
S R Ojeda, and
H F Urbanski, and
K H Katz, and
M E Costa
April 1969,
Endocrinology,
S R Ojeda, and
H F Urbanski, and
K H Katz, and
M E Costa
March 1991,
Endocrinology,
S R Ojeda, and
H F Urbanski, and
K H Katz, and
M E Costa
January 1992,
Biological research,
